Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (ATYR)
NASDAQ:ATYR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 235.00K | $ 353.00K | $ 10.39M | $ 0.00 | $ 10.46M |
| Gross Profit | $ 235.00K | $ 353.00K | $ 8.69M | $ -1.30M | $ -6.84M |
| Operating Income | $ -67.91M | $ -54.92M | $ -46.40M | $ -34.02M | $ -15.91M |
| EBITDA | $ -66.37M | $ -52.18M | $ -44.71M | $ -32.47M | $ -14.64M |
| Net Income | $ -64.02M | $ -50.39M | $ -45.34M | $ -33.77M | $ -16.22M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 72.13M | $ 98.17M | $ 66.15M | $ 107.91M | $ 31.69M |
| Total Assets | $ 96.83M | $ 120.65M | $ 95.79M | $ 115.54M | $ 38.73M |
| Total Debt | $ 13.28M | $ 15.10M | $ 11.53M | $ 1.38M | $ 2.24M |
| Net Debt | $ 2.23M | $ -7.45M | $ 1.55M | $ -958.00K | $ -14.71M |
| Total Liabilities | $ 27.00M | $ 30.18M | $ 24.50M | $ 6.41M | $ 7.24M |
| Stockholders' Equity | $ 70.02M | $ 90.66M | $ 71.46M | $ 109.30M | $ 31.65M |
| Cash Flow | |||||
| Free Cash Flow | $ -69.18M | $ -37.44M | $ -43.53M | $ -33.27M | $ -15.50M |
| Operating Cash Flow | $ -69.12M | $ -33.22M | $ -41.89M | $ -33.08M | $ -15.30M |
| Investing Cash Flow | $ 17.23M | $ -20.13M | $ 47.24M | $ -91.57M | $ 6.90M |
| Financing Cash Flow | $ 39.86M | $ 66.23M | $ 5.45M | $ 110.03M | $ 16.14M |